Serum sialyl Lewis X-i antigen levels in non-small cell lung cancer: Correlation with distant metastasis and survival

Clinical Cancer Research

Volumn 3, Issue 4, 1997, Pages 495-499

  Satoh, Hiroaki ^a   Ishikawa, Hiroichi ^a   Kamma, Hiroshi ^a   Yamashita, Yuko T ^a   Takahashi, Hideto ^a   Ohtsuka, Morio ^a   Hasegawa, Shizuo ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD GROUP LEWIS SYSTEM; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LEWIS BLOOD-GROUP SYSTEM; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; OLIGOSACCHARIDES; SURVIVAL ANALYSIS; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0030906202     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Dennis, J., Waller, C., Timpl, R., and Schirrmacher, V. Surface sialic acid reduces attachment of metastatic tumour cells to collagen type IV and fibronectin. Nature (Lond.), 300: 274-276, 1982.
2. Passaniti, A., and Hart, G. W. Cell surface sialylation and tumor metastasis. Metastatic potential of B16 melanoma variants correlates with their relative numbers of specific penultimate oligosaccharide structures. J. Biol. Chem., 263: 7591-7603, 1988.
3. Hakomori, S. Aberrant glycosylation in cancer cell membranes as focused on glycolipids: overview and perspectives. Cancer Res., 45: 2405-2414, 1985.
4. Hakomori, S. Tumor-associated glycolipid antigens, their metabolism and organization. Chem. Phys. Lipids, 42: 209-233, 1986.
5. Yonezawa, S., Tachikawa, T., Shin, S., and Sato, E. Sialosyl-Tn antigen: its distribution in normal human tissues and expression in adenocarcinomas. Am. J. Clin. Pathol., 98: 167-174, 1992.
6. Matsushita, Y., Cleary, K. R., Ota, D. M., Hoff, S. D., and Irimura, T. Sialyl-dimeric Lewis-X antigen expressed on mucin-like glycoproteins in colorectal cancer metastases. Lab. Invest., 63: 780-791, 1990.
7. Hoff, S. D., Irimura, T., Matsushita, Y., Ota, D. M., Cleary, K. R., and Hakomori, S. Metastatic potential of colon carcinoma. Expression of ABO/Lewis-related antigens. Arch. Surg., 125: 206-209, 1990.
8. Matsushita, Y., Nakamori, S., Sefter, E. A., Hendrix, M. J. C., and Irimura, T. Human colon carcinoma cells with increased invasive capacity obtained by selection for sialyl-dimeric Le X antigen. Exp. Cell Res., 196: 20-25, 1991.
9. Hasegawa, H., Watanabe, M., Arisawa, Y., Teramoto, T., Kodaira, S., and Kitajima, M. Carbohydrate antigens and liver metastasis in colorectal cancer. Jpn. J. Clin. Oncol., 23: 336-341, 1993.
10. Takada, A., Ohmori, K., Yoneda, T., Tsukuoka, K., Hasegawa, A., Kiso, M., and Kannagi, R. Contribution of carbohydrate antigens sialyl Lewis A and sialyl Lewis X to adhesion of human cancer cells to vascular endothelium. Cancer Res., 53: 354-361, 1993.
11. Zenita, K., Kirihara, Y., Kitahara, A., Shigeta, K., Higuchi, K., Hirashima, K., Murachi, T., Miyake, M., Takeda, T., and Kannagi, R. Fucosylated type-2 chain polylactosamine antigen in human lung cancer. Int. J. Cancer, 41: 344-349, 1988.
12. Satoh, H., Yano, H., Naitoh, T., Takahashi, N., Suyama, T., Murayama, J., Kameyama, M., Fukuda, K., Satoh, T., Ohtsuka, M., Yoshizawa, Y., and Hasegawa, S. Determination of various tumor markers, with special reference to sialyl SSEA-1 antigen in lung cancer. Jpn. J. Cancer Chemother, 15: 2917-2922, 1988. (Japanese with English abstract)
13. O'Connell, J. P., Kris, M. G., Gralla, R. J., Groshen, S., Trust, A., Fiore, J. J., Kelsen, D. P., Heelan, R. T., and Golbey, R. B. Frequency and prognostic importance pretreatment clinical characteristics in patients with advanced non-small cell lung cancer treated with combination chemotherapy. J. Clin. Oncol., 4: 1604-1614, 1984.
14. Shinkai, T., Eguchi, K., Sasaki, Y., Tamura, T., Ohe, Y., Kojima, A., Oshita, F., Miya, T., Okamoto, H., Iemura, K., and Saijo, N. A prognostic-factor risk index in advanced non-small cell lung cancer treated with cisplatin-containing combination chemotherapy. Cancer Chemother. Pharmacol., 30: 1-6, 1992.
15. Satoh, H., Yano, H., Ishikawa, H., and Hasegawa, S. Disease extent and response to chemotherapy in non-small cell lung cancer. Acta Oncol., 35: 106-107, 1996.
16. Kannagi, R., Fukushi, Y., Tachikawa, T., Noda, A., Shin, S., Shigeta, K., Hiraiwa, N., Fukuda, Y., Inamoto, T., Hakomori, S., and Imura, H. Quantitative and qualitative characterization of human cancer-associated serum glycoprotein antigens expressing fucosyl or sialylfucosyl type 2 chain polylactosamine. Cancer Res., 46: 2619-2626, 1986.
17. Satoh, H., Kamma, H., Ogata, T., Iijima, T., Shibagaki, T., Yazawa, T., and Hasegawa, S. Expression of SSEA-1-related antigens in adenocarcinoma of the lung, with special reference to the relation to their expression pattern in normal bronchial gland cells. Lung Cancer (Tokyo), 32: 193-199, 1992.
18. De Angelis, G., Cipri, A., Flore, F., and Munno, R. UICC. TNM classification of malignant tumor. 4th ed. Geneva, Switzerland: International Union Against Cancer, 1987.
19. UICC. TNM supplement 1993 A commentary on uniform use. 1993 Springer-Verlag. Berlin, Germany.
20. Hanley, J. A., and McNeil, B. J. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology, 143: 29-36, 1982.
21. Kaplan, E. L., and Meier, P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc., 53: 457-481, 1958.
22. COX, D. R. Regression models and life tables. J. R. Stat. Soc. B, 34: 187-220, 1972.
23. Azuma, A., Yamano, Y., Yoshimura, A., Hibino, T., Nishida, T., Yagita, H., Okumura, K., Seya, T., Kannagi, R., Shibuya, M., and Kudoh, S. Augmented lung adenocarcinoma cytotoxicity by the combination of a genetically modified anti-Lewis Y antibody and antibodies to complement regulatory proteins. Scand. J. Immunol., 42: 202-208, 1995.
24. Kuan, C. T., and Pastan, I. Improved antitumor activity of a recombinant anti-Lewis Y immunotoxin not requiring proteolytic activation. Proc. Natl. Acad. Sci. USA, 93: 974-978, 1996.
25. Stahel, R. A., Lacroix, H., Sculier, J. P., Morant, R., Richner, J., Janzek, E., Loibner, H., and Blythman, H. Phase I/II study of monoclonal antibody against Lewis Y hapten in relapsed small-cell lung cancer. Ann. Oncol., 3: 319-320, 1992.
26. Schlimok, G., Pantel, K., Loibner, H., Fackler-Schwalbe, I., and Riethmüller, G. Reduction of metastatic carcinoma cells in bone marrow by intravenously administered monoclonal antibody: towards a novel surrogate test to monitor adjuvant therapies of solid tumours. Eur. J. Cancer, 31A: 1799-1803, 1995.
27. Lowe, J. B., Stoolman, L. M., Nair, R. P., Larsen, R. D., Berhend, T. L., and Marks, R. M. ELAM-1 -dependent cell adhesion to vascular endothelium determined by a transfected human fucosyltransferase cDNA. Cell, 63: 475-484, 1990.
28. Phillips, M. L., Nudelman, E., Gaeta, F. C. A., Perez, M., Singhal, A. K., Hakomori, S., and Paulson, J. C. ELAM-1 mediates cell adhesion by recognition of a carbohydrate ligand, sialyl-Le X. Science (Washington DC), 250: 1130-1132, 1990.
29. Walz, G., Aruffo, A., Kolanus, W., Bevilacqua, M., and Seed, B. Recognition by ELAM-1 of the sialyl-Le X determinant on myeloid and tumor cells. Science (Washington DC), 250: 1132-1135, 1990.
30. Bevilacqua, M. P., Pober, J. S., Mendrick, D. L., Cotran, R. S., and Gimbrone, M. A. Identification of an inducible endothelial-leukocyte adhesion molecule. Proc. Natl. Acad. Sci. USA, 84: 9238-9242, 1987.
31. Stoolman, L. M. Adhesion molecules controlling lymphocyte migration. Cell, 56: 907-910, 1989.
32. Yogeeswaren, G., and Salk, P. L. Metastatic potential is positively correlated with cell surface sialylation of cultured murine tumor cell lines. Science (Washington DC), 272: 1514-1516, 1981.
33. Schauer, R. Chemistry, metabolism and biological function of sialic acids. Adv. Carbohydr. Chem. Biochem., 40: 131-234, 1982.
34. Altevogt, P., Fogel, M., Cheingsong-Popov, R., Dennis, J., Robinson, P., and Schirrmacher, V. Different patterns of lectin binding and cell surface sialylation detected on related high- and low-metastatic tumor lines. Cancer Res., 43: 5138-5144, 1983.
35. Dennis, J. W., and Laferte, S. Tumor cell surface carbohydrate and the metastatic phenotype. Cancer Metastasis Rev., 5: 185-204, 1987.